The global label-free detection market is projected to reach USD 747 million by 2029 from USD 515 million in 2024, at a CAGR of 7.7% during the forecast period of 2024 to 2029. The growth of the Label-free detection market has been significantly driven by its increasing adoption among pharmaceutical and biotechnology companies for drug discovery application, increasing R&D investment by key players for the development and launch of innovative product and continuous advancements in label-free detection technologies. However, high instrument costs and the technical limitations of label-free detection are restraining market growth.
Scope of the Report
Years Considered for the Study
2022-2029
Base Year
2023
Forecast Period
2024-2029
Units Considered
Value (USD Million)
Segments
Offering, Technology, Application, and End User
Regions covered
North America, Europe, Asia Pacific, Latin America, Middle East and Africa
"The biosensor chips segment under consumables segment accounted for the largest share by offering in 2023."
In 2023, the biosensor chips segment under consumables segment accounted for the largest share by offerings in the global label-free detection market. Biosensors are valuable instruments in the domains of biochemistry and biomedical engineering, as they offer a means of detecting a range of analytes. Label-free biosensors are currently popular in proteomics and biomolecular interaction research because the transducer can detect the chemical or biological agent without the need for dyes, enzymes, or radiolabels. Many tiny compounds are typically found via chromatographic techniques, which are typically expensive, large, and need specialized knowledge. Biosensors provide a quicker and less expensive option. Biosensors offer several benefits over traditional techniques for detecting tiny molecules, such as the ability to monitor in real-time, their high specificity, quick reaction times, minimal need for organic solvents and sample handling, portability, compact design, and simple operation.
"The US has continued to dominate the label-free detection market during the forecast period of 2024-2029."
The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Driven by the growing patient population suffering from infectious disease, increasing biopharmaceuticals' importance, and the necessity of safe and high-quality products in the healthcare sector, demand for label-free detection solutions is predicted to rise in the next years. Because of improved infrastructure, government assistance, and private financing, the country boasts a very developed R&D market. This advances creative and sophisticated research technologies. With label-free detection, which offers reduced turnaround time, and is energy-efficient and provides reliable results, with in a span of time, pharmaceutical companies in the US are actively collaborating in the creation of new reagent and test assays and using it. These elements help the global label-free detection industry to expand.
The primary interviews conducted for this report can be categorized as follows:
By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
List of Companies Profiled in the Report:
Danaher Corporation (US)
Sartorius AG (Germany)
Waters Corporation (US)
REVVITY, INC. (US)
Ametek, Inc. (US)
Horiba, Ltd. (Japan)
Spectris (UK)
Corning Incorporated (US)
Agilent Technologies, Inc. (US)
Shimadzu Corporation (Japan)
Hitachi High-Tech Corporation (Japan)
Attana AB (Sweden)
Bruker Corporation (US)
Bio-Rad Laboratories (US)
ENDRESS+HAUSER Group Services AG (Switzerland)
Becton, Dickinson and Company (US)
Nanotemper Technologies GmBH (Germany)
Affinite Instruments (Canada)
Biosensing Instrument (US)
Unchained Labs.(US)
BioNavis Ltd. (Finland)
Gator Bio (US)
Carterra, Inc. (US)
Nicoya Lifesciences Inc., (Canada)
BiOptix Analytical LLC (US)
Plexera Bioscience (US)
XanTec bioanalytics GmbH (Germany)
BMG Labtech (Germany)
RedShift BioAnalytics, Inc. (US)
lino Biotech AG (Switzerland)
Research Coverage:
This research report categorizes the label-free detection market by offering (Instruments, Consumables (Biosesor Chips, Microplates, Reagents & Kits), Software & Services), by Technology (Surface Plasmon Resonance, Differential Scanning Calorimetry, Bio-layer Interferometry, Isothermal Titration Calorimetry and Other Technologies), by Application (Binding Kinetics, Binding Thermodynamics, HIT Confirmation, Lead Generation, Endogenous Receptor Detection, and Other Application) by end user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organization, and Other End Users) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Label-free detection market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the Label-free detection market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall label-free detection market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Technological advancements in label-free detection, Growing academic-industrial partnerships for drug discovery programs, High sensitivity of label-free technologies, Increasing R&D investments in biotechnology and pharmaceuticals), restraints (High cost of instruments, Technical complexity), opportunities (Growing life sciences research in emerging economies, Rising demand for label-free detection technologies in point of care and portable devices for rapid and on-site analysis in various industry, Increased focus on biomarker discovery), and Challenges (Sample complexity and interference, Stringent regulatory approval process) influencing the growth of the market).
Product Development/Innovation: Detailed insights on newly launched products of the label-free detection market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the label-free detection market
Competitive Assessment: Danaher Corporation (US), Sartorius AG (Germany), Waters Corporation (US), Agilent Technologies, Inc. (US), Corning Incorporated (US), REVVITY, INC. (US), Ametek, Inc. (US), Horiba, Ltd. (Japan), Spectris (UK), Shimadzu Corporation (Japan), Hitachi High-Tech Corporation (Japan), Attana AB (Sweden), Bruker Corporation (US), Bio-Rad Laboratories (US), ENDRESS+HAUSER Group Services AG (Switzerland), Becton, Dickinson and Company (US), among others in the market.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.2 MARKET SIZE ESTIMATION
2.2.1 GLOBAL MARKET ESTIMATION
2.2.2 INSIGHTS OF PRIMARY EXPERTS
2.2.3 SEGMENTAL MARKET SIZE ESTIMATION
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 MARKET LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 LABEL-FREE DETECTION MARKET OVERVIEW
4.2 NORTH AMERICA: LABEL-FREE DETECTION MARKET SHARE, BY OFFERING AND COUNTRY (2023)
4.3 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER & COUNTRY (2023)
4.4 LABEL-FREE DETECTION MARKET SHARE, BY END USER, 2023